|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:awards
|
gptkb:Dun_&_Bradstreet_Corporate_Awards
gptkb:Golden_Peacock_Award_for_Risk_Management
|
|
gptkbp:CEO
|
gptkb:Jonathan_Hunt
|
|
gptkbp:country
|
gptkb:India
|
|
gptkbp:founded
|
1993
|
|
gptkbp:founder
|
gptkb:Kiran_Mazumdar-Shaw
|
|
gptkbp:headquarters_location
|
gptkb:Bangalore
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Syngene International
|
|
gptkbp:industry
|
gptkb:biotechnology
contract research organization
|
|
gptkbp:keyPerson
|
gptkb:Jonathan_Hunt
gptkb:Kiran_Mazumdar-Shaw
|
|
gptkbp:listedOn
|
gptkb:BSE:_539268
NSE: SYNGENE
|
|
gptkbp:notableClient
|
gptkb:Bayer
gptkb:GSK
gptkb:Baxter
gptkb:AbbVie
gptkb:Amgen
gptkb:Merck
gptkb:Bristol-Myers_Squibb
pharmaceutical companies
biotechnology companies
agrochemical companies
animal health companies
|
|
gptkbp:numberOfEmployees
|
over 6000
|
|
gptkbp:parentCompany
|
gptkb:Biocon_Limited
|
|
gptkbp:research_facility_location
|
gptkb:Bangalore
gptkb:Hyderabad
gptkb:Mangalore
|
|
gptkbp:revenue_(FY23)
|
INR 3,207 crore
|
|
gptkbp:servesArea
|
global
|
|
gptkbp:services
|
manufacturing services
development services
discovery research
|
|
gptkbp:specialty
|
manufacturing
biologics
biopharmaceuticals
oligonucleotides
antibody-drug conjugates
analytical services
cell and gene therapy
clinical development
chemical development
small molecule research
|
|
gptkbp:stockExchange
|
gptkb:NSE
BSE
|
|
gptkbp:subsidiary
|
gptkb:Biocon_Group
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.syngeneintl.com/
|
|
gptkbp:bfsParent
|
gptkb:Biocon_Limited
|
|
gptkbp:bfsLayer
|
6
|